KFDA definition

KFDA means Korean Food and Drug Administration, or any successor agency thereto.
KFDA means Korean Food and Drug Administration;
KFDA means the Korea Food & Drug Administration and any successor thereto.

Examples of KFDA in a sentence

  • KFDA 2011 Instruction on new certification requirements for Japanese food, (Exhibit KOR-40.b).

  • KFDA conducts the conformity assessment from the information collected, using such items as test results, document inspection results, etc.

  • If a product complies with the Korean standards, KFDA issues a certificate for import.

  • November 2012 | News | By BioSpectrum Bureau Korea FDA accepts IND application by Hanim for KX-01 Singapore: Korean Food and Drug Administration (KFDA) has accepted Hanmi Pharmaceutical's investigational new drug application for KX-01, dual src/pretubulin inhibitor by Kinex Pharmaceuticals, in the oncologic setting.

  • However, some people in the project area might have to be resettled by the government as a result of the recently passed Land Bill for the country.

  • The Korea Food & Drug Administration (KFDA) under MHW is responsible for executing all inspections.

  • KFDA regional offices inspect labeling of imported food products upon arrival.

  • KFDA 2011 Instruction on new certification requirements for Japanese food, (Exhibit KOR-40.b).7.47.

  • If a product is subject to organoleptic inspection, laboratory inspection and random sampling examination, the KFDA inspector will conduct a field examination and take samples for the laboratory test.

  • If a minor violation can be corrected, as with labels, the importer can reapply for inspection after making the corrections.For perishable agricultural products, such as fresh vegetables, fruits, etc., an importer can clear the products prior to completion of the laboratory test with a pre-certification authorization from KFDA.

Related to KFDA

  • MFDA means the Mutual Fund Dealers Association of Canada;

  • CFDA means the Code of Federal Domestic Assistance assigned to a federal grant.

  • FDA means the United States Food and Drug Administration and any successor agency thereto.

  • PMDA means Japan’s Pharmaceuticals and Medical Devices Agency or any successor entity thereto.

  • in vitro diagnostic medical device means any medical device which is a reagent, reagent product, calibrator, control material, kit, instrument, apparatus, equipment, software or system, whether used alone or in combination, intended by the manufacturer to be used in vitro for the examination of specimens, including blood and tissue donations, derived from the human body, solely or principally for the purpose of providing information:

  • Regulatory Authorities means the Commissions and the Exchange;

  • Investigational Medicinal Product means the study drug or control material as defined in the Protocol.

  • competent authorities means the competent authorities of the Member States as identified on the websites listed in Annex II;

  • Clinical evaluation means a systematic and planned process to continuously generate, collect, analyse and assess the clinical data pertaining to a device in order to verify the safety and performance, including clinical benefits, of the device when used as intended by the manufacturer;

  • contracting authorities means the State, regional or local authorities, bodies governed by public law or associations formed by one or more such authorities or one or more such bodies governed by public law;

  • Marketing Authorisation means any approval (including all applicable pricing and governmental reimbursement approvals) required from the FDA or relevant Competent Authority to market and sell a Product in a particular country.

  • Public Procurement Regulatory Authority (PPRA) means the Government Agency responsible for oversight of public procurement.

  • Marketing Authorization means all approvals from the relevant Regulatory Authority necessary to market and sell a Product in any country (including without limitation, all applicable pricing and governmental reimbursement approvals even if not legally required to sell Product in a country).

  • Investigational Product means the Study Drug identified above and the control material, as further detailed in the Protocol;

  • Protocol means, in respect of any category of object and associated rights to which this Convention applies, the Protocol in respect of that category of object and associated rights;

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • EMEA means the European Medicines Agency.

  • Medical marijuana product means a product that contains cannabinoids that have been extracted from plant material or the resin therefrom by physical or chemical means and is intended for administration to a licensed patient, including but not limited to concentrates, oils, tinctures, edibles, pills, topical forms, gels, creams, and other derivative forms, except that this term does not include live plant forms.

  • Approved clinical trial means a phase I, phase II, phase III, or phase IV clinical trial that is conducted in relation to the prevention, detection, or treatment of cancer or other life-threatening disease or Condition and is described in any of the following:

  • Marketing Approval Application or “MAA” means a New Drug Application (or its equivalent), as defined in the U.S. Food, Drug and Cosmetic Act and the regulations promulgated thereunder, or any corresponding or similar application, registration or certification in any country.

  • Health Authority means the regional health board designated under the Health Authority Act, RSBC 1996, c.180, or the Provincial Health Services Authority, to which the Participant is designated under Section 5.4 of this Contract, unless designated otherwise by the Province;

  • Regulatory Authority means any applicable supra-national, federal, national, regional, state, provincial or local regulatory agencies, departments, bureaus, commissions, councils or other government entities regulating or otherwise exercising authority with respect to the Exploitation of a Licensed Compound or a Licensed Product in the Territory.

  • Relevant Electric Retail Regulatory Authority means an entity that has jurisdiction over and establishes prices and policies for competition for providers of retail electric service to end- customers, such as the city council for a municipal utility, the governing board of a cooperative utility, the state public utility commission or any other such entity.

  • Regulatory Body means those government departments and regulatory, statutory and other entities, committees, ombudsmen and bodies which, whether under statute, rules, regulations, codes of practice or otherwise, are entitled to regulate or investigate the matters dealt with in this Agreement or any other affairs of the Provider or the Department, including, without limitation Ofsted, the European Commission and the European Court of Auditors;

  • Pharmaceutical Product shall have the meaning ascribed to such term in Section 3.1(hh).

  • EMA means the European Medicines Agency or any successor agency thereto.